Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
101
3.030
 Why?
Ophthalmologic Surgical Procedures
5
2017
57
2.230
 Why?
Angiogenesis Inhibitors
11
2022
215
2.040
 Why?
Retina
11
2016
263
1.760
 Why?
Glaucoma
4
2017
202
1.660
 Why?
Alloys
4
2013
30
1.630
 Why?
Eye Foreign Bodies
5
2016
23
1.620
 Why?
Macular Edema
4
2022
34
1.580
 Why?
Retinal Detachment
6
2019
53
1.540
 Why?
Vitrectomy
7
2019
57
1.500
 Why?
Diabetic Retinopathy
6
2019
149
1.490
 Why?
Glaucoma Drainage Implants
3
2016
47
1.430
 Why?
Retinal Diseases
5
2017
76
1.280
 Why?
Intraocular Pressure
7
2017
276
1.260
 Why?
Nanopores
2
2020
4
1.230
 Why?
Intravitreal Injections
7
2022
45
1.210
 Why?
Membranes, Artificial
2
2020
65
1.190
 Why?
Nanotechnology
2
2020
113
1.120
 Why?
Suction
3
2015
31
1.040
 Why?
Sutures
3
2015
50
0.990
 Why?
Choroidal Neovascularization
4
2011
44
0.980
 Why?
Anterior Eye Segment
2
2017
9
0.970
 Why?
Swine
10
2017
700
0.960
 Why?
Suture Techniques
3
2015
115
0.950
 Why?
Equipment Design
6
2017
508
0.920
 Why?
Lens Implantation, Intraocular
2
2015
57
0.890
 Why?
Retinitis
1
2022
17
0.820
 Why?
Retinal Vasculitis
1
2022
7
0.820
 Why?
Aneurysm
1
2022
29
0.800
 Why?
Antibodies, Monoclonal
6
2020
1270
0.770
 Why?
Vitreoretinopathy, Proliferative
2
2019
10
0.750
 Why?
Vascular Endothelial Growth Factor A
6
2020
498
0.740
 Why?
Immunosuppressive Agents
3
2013
647
0.720
 Why?
Retinal Vessels
2
2015
50
0.720
 Why?
Disease Models, Animal
8
2020
3542
0.720
 Why?
Durapatite
1
2020
31
0.710
 Why?
Cytomegalovirus Retinitis
2
2013
17
0.700
 Why?
Complement System Proteins
2
2020
285
0.690
 Why?
Isoxazoles
2
2013
52
0.690
 Why?
Eye Injuries, Penetrating
3
2016
17
0.680
 Why?
Endophthalmitis
2
2017
25
0.680
 Why?
Scleral Buckling
3
2012
18
0.680
 Why?
Stents
2
2013
475
0.650
 Why?
Fluorocarbons
2
2012
94
0.600
 Why?
Glucocorticoids
2
2020
532
0.580
 Why?
Anterior Chamber
1
2017
19
0.570
 Why?
Transducers
1
2017
25
0.570
 Why?
Strabismus
1
2017
26
0.560
 Why?
Sclera
2
2015
35
0.540
 Why?
Filtering Surgery
1
2016
22
0.540
 Why?
Trabeculectomy
1
2017
65
0.530
 Why?
Surgical Instruments
2
2013
48
0.530
 Why?
Fovea Centralis
2
2006
8
0.520
 Why?
Laser Therapy
1
2017
100
0.510
 Why?
Retinal Perforations
2
2005
12
0.510
 Why?
Ocular Hypertension
1
2016
61
0.510
 Why?
Drug Resistance, Multiple, Viral
2
2013
11
0.510
 Why?
Ophthalmology
2
2013
77
0.500
 Why?
Lenses, Intraocular
1
2015
42
0.490
 Why?
Monitoring, Physiologic
1
2017
248
0.490
 Why?
Tomography, Optical Coherence
7
2015
130
0.490
 Why?
Lasers
1
2015
121
0.490
 Why?
Device Removal
1
2016
126
0.480
 Why?
Antiviral Agents
2
2013
646
0.470
 Why?
Prostheses and Implants
1
2016
138
0.470
 Why?
Ischemia
2
2017
362
0.460
 Why?
Fluorescein Angiography
9
2012
102
0.460
 Why?
Animals
18
2020
31762
0.460
 Why?
Rabbits
3
2020
736
0.450
 Why?
Models, Cardiovascular
1
2015
178
0.440
 Why?
Retinal Degeneration
2
2015
30
0.440
 Why?
Artificial Lens Implant Migration
1
2013
3
0.430
 Why?
Choroid
3
2015
47
0.430
 Why?
Macular Degeneration
6
2015
152
0.430
 Why?
Viscosupplements
1
2012
10
0.420
 Why?
Gravitation
1
2012
20
0.420
 Why?
Silicone Oils
1
2012
26
0.420
 Why?
Silicon
1
2012
13
0.410
 Why?
Pupil Disorders
1
2012
5
0.410
 Why?
Viremia
1
2013
123
0.410
 Why?
Eye Enucleation
1
2012
12
0.410
 Why?
Iris
1
2012
19
0.410
 Why?
Quantum Dots
1
2012
35
0.410
 Why?
Silicone Elastomers
1
2012
7
0.400
 Why?
Prosthesis Implantation
1
2013
139
0.400
 Why?
Uveitis, Posterior
1
2012
12
0.400
 Why?
Surgical Stapling
1
2012
9
0.400
 Why?
Fluocinolone Acetonide
1
2012
16
0.390
 Why?
Electric Stimulation Therapy
1
2012
56
0.390
 Why?
Vitreous Hemorrhage
2
2015
6
0.390
 Why?
Cataract Extraction
1
2013
76
0.390
 Why?
Models, Biological
4
2015
1630
0.380
 Why?
Vascular Endothelial Growth Factors
1
2011
61
0.380
 Why?
Humans
47
2022
114757
0.360
 Why?
Oxygen
1
2015
853
0.350
 Why?
Materials Testing
1
2012
337
0.350
 Why?
Cytomegalovirus
2
2013
144
0.350
 Why?
Anti-Inflammatory Agents
1
2012
450
0.310
 Why?
Biocompatible Materials
1
2012
369
0.300
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
253
0.300
 Why?
Electroretinography
5
2016
40
0.290
 Why?
von Hippel-Lindau Disease
1
2007
11
0.280
 Why?
Antibodies, Monoclonal, Humanized
6
2015
664
0.280
 Why?
Injections
5
2012
159
0.280
 Why?
Pigment Epithelium of Eye
2
2006
34
0.270
 Why?
Puerperal Disorders
1
2007
30
0.270
 Why?
Drug Implants
2
2020
70
0.270
 Why?
Recombinant Fusion Proteins
4
2022
617
0.270
 Why?
Uveal Diseases
1
2006
5
0.270
 Why?
Ocular Hypotension
1
2006
10
0.270
 Why?
Fusobacterium Infections
1
2006
6
0.260
 Why?
Female
26
2022
59507
0.260
 Why?
Dementia
2
2022
187
0.260
 Why?
Pharyngeal Diseases
1
2006
12
0.260
 Why?
Needles
2
2017
49
0.260
 Why?
Epiretinal Membrane
1
2005
6
0.260
 Why?
Visual Acuity
7
2019
274
0.260
 Why?
Ciliary Body
1
2006
33
0.260
 Why?
Telangiectasis
1
2005
6
0.260
 Why?
Rats, Inbred BN
3
2011
52
0.250
 Why?
Uveitis
1
2006
115
0.250
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
103
0.240
 Why?
Kidney Transplantation
2
2013
541
0.240
 Why?
Middle Aged
17
2019
26757
0.240
 Why?
Injections, Intraocular
2
2015
10
0.230
 Why?
Polypropylenes
2
2015
14
0.230
 Why?
Autoimmune Diseases
1
2006
391
0.210
 Why?
Laser Coagulation
3
2012
54
0.210
 Why?
Bevacizumab
6
2015
115
0.210
 Why?
Optic Atrophy
1
2022
10
0.210
 Why?
Hearing Loss, Central
1
2022
5
0.210
 Why?
Rats
4
2012
4943
0.200
 Why?
Retinal Vein Occlusion
2
2015
13
0.190
 Why?
Cell Count
2
2012
305
0.190
 Why?
Male
21
2019
55579
0.180
 Why?
Dialysis
1
2020
17
0.180
 Why?
Adult
11
2022
30548
0.180
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
10
0.180
 Why?
Orbital Neoplasms
1
2000
21
0.180
 Why?
Time Factors
4
2017
6124
0.180
 Why?
Follow-Up Studies
5
2015
4420
0.180
 Why?
Adsorption
1
2020
119
0.170
 Why?
Biomarkers
2
2020
3416
0.170
 Why?
Wet Macular Degeneration
1
2019
32
0.160
 Why?
Geographic Atrophy
1
2019
49
0.160
 Why?
Fluorescein-5-isothiocyanate
2
2009
37
0.150
 Why?
Eye Diseases, Hereditary
1
2018
11
0.150
 Why?
Miniaturization
2
2015
23
0.150
 Why?
Hypertension
1
2006
1059
0.150
 Why?
Dextrans
2
2009
74
0.150
 Why?
Iris Diseases
1
2017
5
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
797
0.140
 Why?
Choroid Diseases
1
2017
9
0.140
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
13
0.140
 Why?
Aged, 80 and over
6
2019
6350
0.140
 Why?
Dark Adaptation
2
2012
13
0.140
 Why?
Antimony
1
2016
4
0.140
 Why?
Aged
10
2020
19094
0.140
 Why?
Infliximab
2
2007
94
0.140
 Why?
Dose-Response Relationship, Drug
3
2014
1846
0.140
 Why?
Polymers
1
2020
447
0.130
 Why?
Treatment Outcome
9
2016
9089
0.130
 Why?
Pressure
1
2017
218
0.130
 Why?
Sclerostomy
1
2015
4
0.130
 Why?
Foreign-Body Migration
1
2016
37
0.130
 Why?
Gyrate Atrophy
1
2015
2
0.130
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1183
0.130
 Why?
Down Syndrome
1
2000
338
0.130
 Why?
Vitreoretinal Surgery
1
2015
3
0.120
 Why?
Eye Infections, Bacterial
1
2015
26
0.120
 Why?
Stress, Mechanical
1
2017
445
0.120
 Why?
Vitreous Detachment
1
2015
5
0.120
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
36
0.120
 Why?
Equipment Failure Analysis
1
2015
132
0.120
 Why?
Partial Pressure
1
2015
30
0.120
 Why?
Hemoglobin SC Disease
1
2015
15
0.120
 Why?
Feedback
1
2015
144
0.120
 Why?
Biopsy, Needle
1
2015
181
0.120
 Why?
Protein Binding
1
2020
1897
0.120
 Why?
Prosthesis Failure
1
2016
117
0.120
 Why?
Oculomotor Muscles
1
2014
40
0.120
 Why?
International Normalized Ratio
1
2014
45
0.120
 Why?
Postoperative Care
1
2015
219
0.110
 Why?
Diabetes Mellitus, Type 2
2
2012
2097
0.110
 Why?
Exchange Transfusion, Whole Blood
1
2013
15
0.110
 Why?
In Vitro Techniques
1
2015
1013
0.110
 Why?
Retinal Artery Occlusion
1
2013
8
0.110
 Why?
Warfarin
1
2014
135
0.110
 Why?
Tendons
1
2014
120
0.110
 Why?
Metabolomics
1
2018
527
0.110
 Why?
Research Design
1
2019
931
0.110
 Why?
Specific Gravity
1
2012
11
0.110
 Why?
Transducers, Pressure
1
2012
13
0.110
 Why?
Erythrocyte Transfusion
1
2015
186
0.110
 Why?
Antineoplastic Agents
2
2020
1895
0.110
 Why?
Adaptation, Ocular
1
2012
4
0.100
 Why?
Minerals
1
2012
37
0.100
 Why?
Rats, Mutant Strains
1
2012
25
0.100
 Why?
Viscosity
1
2012
81
0.100
 Why?
Adolescent
4
2019
17808
0.100
 Why?
Pupil
1
2012
13
0.100
 Why?
Acetates
1
2012
95
0.100
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.100
 Why?
Retinal Neovascularization
1
2012
20
0.100
 Why?
Endothelium, Corneal
1
2012
15
0.100
 Why?
Sodium Chloride
1
2012
136
0.100
 Why?
Electrodes, Implanted
1
2012
91
0.100
 Why?
Drug Combinations
1
2012
286
0.100
 Why?
Swine, Miniature
1
2012
71
0.100
 Why?
Tumor Necrosis Factor-alpha
2
2007
1134
0.100
 Why?
Microsurgery
1
2012
59
0.100
 Why?
Retinal Ganglion Cells
1
2012
92
0.100
 Why?
Gold
1
2012
106
0.100
 Why?
Bruch Membrane
1
2011
6
0.100
 Why?
Registries
1
2019
1759
0.100
 Why?
Polyglycolic Acid
1
2011
43
0.090
 Why?
Administration, Oral
1
2013
731
0.090
 Why?
Drug Compounding
1
2011
89
0.090
 Why?
Retrospective Studies
8
2015
12515
0.090
 Why?
Computer Simulation
1
2015
878
0.090
 Why?
Dissection
1
2011
50
0.090
 Why?
Delayed-Action Preparations
1
2011
159
0.090
 Why?
Atrial Fibrillation
1
2014
324
0.090
 Why?
Anemia, Sickle Cell
1
2013
216
0.090
 Why?
Models, Animal
1
2012
345
0.090
 Why?
Lactic Acid
1
2011
275
0.080
 Why?
Bacteria
1
2015
726
0.080
 Why?
Cell Survival
1
2012
1021
0.080
 Why?
Scotoma
1
2008
4
0.080
 Why?
Proliferating Cell Nuclear Antigen
1
2007
49
0.070
 Why?
Severity of Illness Index
2
2014
2539
0.070
 Why?
Pilot Projects
1
2012
1370
0.070
 Why?
Optic Neuropathy, Ischemic
1
2007
30
0.070
 Why?
Papilledema
1
2007
40
0.070
 Why?
Visual Fields
3
2007
77
0.070
 Why?
Young Adult
2
2019
10463
0.070
 Why?
RNA, Catalytic
1
2007
182
0.070
 Why?
Retinitis Pigmentosa
1
2006
16
0.070
 Why?
Glycogen Storage Disease Type IIb
1
2006
22
0.070
 Why?
Polyethylene Glycols
1
2011
561
0.070
 Why?
Triamcinolone Acetonide
1
2006
27
0.070
 Why?
Fusobacterium necrophorum
1
2006
1
0.070
 Why?
Indocyanine Green
1
2005
12
0.070
 Why?
Myopia
1
2006
36
0.070
 Why?
Vision, Low
3
2013
14
0.070
 Why?
Coloring Agents
1
2005
72
0.060
 Why?
Eye Injuries
1
2006
45
0.060
 Why?
Infusions, Intravenous
1
2006
372
0.060
 Why?
Staining and Labeling
1
2005
134
0.060
 Why?
Syndrome
1
2006
334
0.060
 Why?
Cataract
1
2006
185
0.060
 Why?
Multivariate Analysis
2
2019
1435
0.050
 Why?
Diagnosis, Differential
1
2007
1340
0.050
 Why?
Ranibizumab
2
2013
18
0.050
 Why?
Blindness
2
2013
37
0.050
 Why?
Postoperative Complications
1
2012
2127
0.050
 Why?
Keratitis
1
2000
11
0.040
 Why?
Exophthalmos
1
2000
19
0.040
 Why?
Chronic Disease
1
2006
1590
0.040
 Why?
Immunophenotyping
1
2000
275
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2269
0.040
 Why?
Xanthine
1
2018
7
0.040
 Why?
Combined Modality Therapy
2
2013
1122
0.040
 Why?
Electrooculography
1
1997
10
0.040
 Why?
Visual Field Tests
1
1997
13
0.040
 Why?
Color Vision Defects
1
1997
6
0.040
 Why?
Fundus Oculi
1
1997
40
0.040
 Why?
Purines
1
2018
159
0.040
 Why?
Cohort Studies
2
2019
4901
0.040
 Why?
Child
2
2015
18352
0.030
 Why?
Odds Ratio
1
2019
954
0.030
 Why?
Photic Stimulation
1
1997
203
0.030
 Why?
Vision Disorders
1
1997
130
0.030
 Why?
Microbiological Techniques
1
2015
29
0.030
 Why?
Colony Count, Microbial
1
2015
111
0.030
 Why?
Myopia, Degenerative
1
2015
3
0.030
 Why?
Metabolome
1
2018
283
0.030
 Why?
Endotamponade
1
2015
4
0.030
 Why?
Pregnancy
1
2007
5525
0.030
 Why?
Disease Progression
2
2015
2387
0.030
 Why?
Tissue Adhesions
1
2015
25
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Mass Spectrometry
1
2018
633
0.030
 Why?
Photography
1
2015
89
0.030
 Why?
Atrophy
1
2015
152
0.030
 Why?
Biometry
1
2014
63
0.030
 Why?
Conjunctiva
1
2014
51
0.030
 Why?
Risk Factors
2
2019
8627
0.030
 Why?
Glucose
1
2018
897
0.030
 Why?
Fatty Acids, Omega-3
1
2014
122
0.030
 Why?
Risk Assessment
2
2014
2973
0.030
 Why?
Oxidative Stress
1
2018
1084
0.020
 Why?
Retreatment
1
2012
67
0.020
 Why?
Kaplan-Meier Estimate
1
2014
815
0.020
 Why?
Global Health
1
2014
288
0.020
 Why?
Proportional Hazards Models
1
2014
1080
0.020
 Why?
Phenotype
1
2019
2812
0.020
 Why?
Survival Analysis
1
2014
1218
0.020
 Why?
Health Care Costs
1
2014
380
0.020
 Why?
Antioxidants
1
2014
530
0.020
 Why?
Anticoagulants
1
2014
547
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
373
0.020
 Why?
Comorbidity
1
2014
1449
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
59
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
46
0.020
 Why?
Colorado
1
2019
4086
0.020
 Why?
Prospective Studies
2
2012
6217
0.020
 Why?
Retinal Artery
1
2007
15
0.020
 Why?
Infant
1
2000
7935
0.020
 Why?
Cerebral Angiography
1
2007
109
0.020
 Why?
Prognosis
1
2014
3334
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
26
0.020
 Why?
Frameshift Mutation
1
2006
27
0.020
 Why?
Anti-Bacterial Agents
1
2015
1477
0.020
 Why?
Secondary Prevention
1
2007
222
0.020
 Why?
Adrenal Cortex Hormones
1
2008
498
0.010
 Why?
Double-Blind Method
1
2007
1662
0.010
 Why?
RNA, Messenger
1
2007
2557
0.010
 Why?
Aging
1
2008
1620
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)